Education
About Us
Working with TipRanks
Follow Us
Oncosec Medical Incorporated (ONCSQ)
:ONCSQ
Total Valuation
OncoSec Medical has a market cap or net worth of $6.00. The enterprise value is -$3.20M.
Market Cap$6.00
Enterprise Value-$3.20M
Share Statistics
OncoSec Medical has 5,962,652 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding5,962,652
Owned by Insiders―
Owned by Institutions2.12%
Financial Efficiency
OncoSec Medical’s return on equity (ROE) is -5.59 and return on invested capital (ROIC) is -195.00%.
Return on Equity (ROE)-5.59
Return on Assets (ROA)-1.56
Return on Invested Capital (ROIC)-195.00%
Return on Capital Employed (ROCE)-2.43
Revenue Per Employee0.00
Profits Per Employee-854.49K
Employee Count40
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of OncoSec Medical is -0.09. OncoSec Medical’s PEG ratio is <0.01.
PE Ratio-0.09
PS Ratio0.00
PB Ratio0.48
Price to Fair Value0.48
Price to FCF-0.09
Price to Operating Cash Flow-0.09
PEG Ratio<0.01
Income Statement
In the last 12 months, OncoSec Medical had revenue of 0.00 and earned -34.18M in profits. Earnings per share was -19.13.
Revenue0.00
Gross Profit-1.07M
Operating Income-37.01M
Pretax Income-37.51M
Net Income-34.18M
EBITDA-36.43M
Earnings Per Share (EPS)-19.13
Cash Flow
In the last 12 months, operating cash flow was -24.99M and capital expenditures -15.96K, giving a free cash flow of -25.01M billion.
Operating Cash Flow-24.99M
Free Cash Flow-25.01M
Free Cash Flow per Share-4.19
Dividends & Yields
OncoSec Medical pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta-51.72
52-Week Price Change―
50-Day Moving Average―
200-Day Moving Average―
Relative Strength Index (RSI)100.00
Average Volume (3m)0.00
Important Dates
OncoSec Medical upcoming earnings date is Mar 12, 2025, TBA Not Confirmed.
Last Earnings DateMar 13, 2024
Next Earnings DateMar 12, 2025
Ex-Dividend Date―
Financial Position
OncoSec Medical as a current ratio of 2.30, with Debt / Equity ratio of 100.92%
Current Ratio2.30
Quick Ratio2.30
Debt to Market Cap0.32
Net Debt to EBITDA0.17
Interest Coverage Ratio-1.77K
Taxes
In the past 12 months, OncoSec Medical has paid -3.33M in taxes.
Income Tax-3.33M
Effective Tax Rate0.09
Enterprise Valuation
OncoSec Medical EV to EBITDA ratio is 0.09, with an EV/FCF ratio of 0.10.
EV to Sales0.00
EV to EBITDA0.09
EV to Free Cash Flow0.10
EV to Operating Cash Flow0.10
Balance Sheet
OncoSec Medical has $3.68M in cash and marketable securities with $3.46M in debt, giving a net cash position of -$219.12K billion.
Cash & Marketable Securities$3.68M
Total Debt$3.46M
Net Cash-$219.12K
Net Cash Per Share-$0.04
Tangible Book Value Per Share$3.21
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for OncoSec Medical is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―